학술논문

Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Document Type
Article
Source
In Clinical Lung Cancer May 2019 20(3):222-230
Subject
Language
ISSN
1525-7304